Supplemental Table 1 for: Real-world trends in biologic, oral systemic and phototherapy in United States patients with psoriasis or psoriatic arthritis

Table_1_Major cardiovascular events under biologic psoriasis therapies: a 19-year real-world analysis of FAERS data.docx

Lingqing Ding (17916311)
Congqin Chen (17916314)
Yongkuan Yang (17916317)
Xiaoting Zhang (439516)

February 2024

ObjectiveOver the years when biologic psoriasis therapies (TNF inhibitors, IL-12/23 inhibitors, IL-2...

Supplemental Material, Appendix_2_Panel,_Teams_Involved - 2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis

Jasvinder A. Singh (484385)
Gordon Guyatt (56595)
Alexis Ogdie (6060134)
Dafna D. Gladman (4522396)
Chad Deal (6060137)
Atul Deodhar (3606365)
Maureen Dubreuil (6060140)
Jonathan Dunham (6060143)
M. Elaine Husni (5005829)
Sarah Kenny (6060146)
Jennifer Kwan-Morley (6060149)
Janice Lin (1961875)
Paula Marchetta (6060152)
Philip J. Mease (4910524)
Joseph F. Merola (5365979)
Julie Miner (6060155)
Christopher T. Ritchlin (647915)
Bernadette Siaton (6060158)
Benjamin J. Smith (332956)
Abby S. Van Voorhees (6060161)
Anna Helena Jonsson (6060164)
Amit Aakash Shah (6060167)
Nancy Sullivan (6060170)
Marat Turgunbaev (6060173)
Laura C. Coates (5081063)
Alice Gottlieb (218992)
Marina Magrey (3945329)
W. Benjamin Nowell (6060176)
Ana-Maria Orbai (797190)
Soumya M. Reddy (6060179)
Jose U. Scher (6060182)
Evan Siegel (6060185)
Michael Siegel (1481731)
Jessica A. Walsh (5585778)
Amy S. Turner (6060188)
James Reston (6060191)

December 2018

Supplemental Material, Appendix_2_Panel,_Teams_Involved for 2018 American College of Rheumatology/Na...

Supplemental Material, Appendixs5_revised - 2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis

Jasvinder A. Singh (484385)
Gordon Guyatt (56595)
Alexis Ogdie (6060134)
Dafna D. Gladman (4522396)
Chad Deal (6060137)
Atul Deodhar (3606365)
Maureen Dubreuil (6060140)
Jonathan Dunham (6060143)
M. Elaine Husni (5005829)
Sarah Kenny (6060146)
Jennifer Kwan-Morley (6060149)
Janice Lin (1961875)
Paula Marchetta (6060152)
Philip J. Mease (4910524)
Joseph F. Merola (5365979)
Julie Miner (6060155)
Christopher T. Ritchlin (647915)
Bernadette Siaton (6060158)
Benjamin J. Smith (332956)
Abby S. Van Voorhees (6060161)
Anna Helena Jonsson (6060164)
Amit Aakash Shah (6060167)
Nancy Sullivan (6060170)
Marat Turgunbaev (6060173)
Laura C. Coates (5081063)
Alice Gottlieb (218992)
Marina Magrey (3945329)
W. Benjamin Nowell (6060176)
Ana-Maria Orbai (797190)
Soumya M. Reddy (6060179)
Jose U. Scher (6060182)
Evan Siegel (6060185)
Michael Siegel (1481731)
Jessica A. Walsh (5585778)
Amy S. Turner (6060188)
James Reston (6060191)

December 2018

Supplemental Material, Appendixs5_revised for 2018 American College of Rheumatology/National Psorias...

Supplemental Table 1 for: Real-world trends in biologic, oral systemic and phototherapy in United States patients with psoriasis or psoriatic arthritis

Singh, P

Supplemental Table 1 for "Real-world trends in biologic, oral systemic and phototherapy in United St...

Supplement_Table_S1 – Supplemental material for Effectiveness and safety of secukinumab for psoriasis in real-world practice: analysis of subgroups stratified by prior biologic failure or reimbursement

Tzong-Yun Ger (6599690)
Yu-Huei Huang (6599693)
Rosaline Chung-yee Hui (6599696)
Tsen-Fang Tsai (799942)
Hsien-Yi Chiu (799936)

April 2019

Supplemental material, Supplement_Table_S1 for Effectiveness and safety of secukinumab for psoriasis...

Supplement_Table_S2 – Supplemental material for Effectiveness and safety of secukinumab for psoriasis in real-world practice: analysis of subgroups stratified by prior biologic failure or reimbursement

Tzong-Yun Ger (6599690)
Yu-Huei Huang (6599693)
Rosaline Chung-yee Hui (6599696)
Tsen-Fang Tsai (799942)
Hsien-Yi Chiu (799936)

April 2019

Supplemental material, Supplement_Table_S2 for Effectiveness and safety of secukinumab for psoriasis...

Supplement_Table_S3 – Supplemental material for Effectiveness and safety of secukinumab for psoriasis in real-world practice: analysis of subgroups stratified by prior biologic failure or reimbursement

Tzong-Yun Ger (6599690)
Yu-Huei Huang (6599693)
Rosaline Chung-yee Hui (6599696)
Tsen-Fang Tsai (799942)
Hsien-Yi Chiu (799936)

April 2019

Supplemental material, Supplement_Table_S3 for Effectiveness and safety of secukinumab for psoriasis...

Supplement_Table_S4 – Supplemental material for Effectiveness and safety of secukinumab for psoriasis in real-world practice: analysis of subgroups stratified by prior biologic failure or reimbursement

Tzong-Yun Ger (6599690)
Yu-Huei Huang (6599693)
Rosaline Chung-yee Hui (6599696)
Tsen-Fang Tsai (799942)
Hsien-Yi Chiu (799936)

April 2019

Supplemental material, Supplement_Table_S4 for Effectiveness and safety of secukinumab for psoriasis...

Table S1 -Supplemental material for Quantitative evaluation to efficacy and safety of therapies for psoriasis: A network meta-analysis

Jingjing Lv (5276036)
Dongmei Zhou (786550)
Yan Wang (15435)
Jingxia Zhao (5276045)
Zhaoxia Chen (5276039)
Jinchao Zhang (1324296)
Tingting Di (5276042)
Jing Hu (41899)
Bo Li (112195)
Ping Li (31981)
Feng Huang (62988)

May 2018

<p>Supplemental material, Table S1 for Quantitative evaluation to efficacy and safety of therapies f...

Supplemental Table: Medicaid coverage per state for biologic medications and Apremilast in the systemic treatment of psoriasis

Falotico, J (via Mendeley Data)

November 2021

Supplemental TableTHIS DATASET IS ARCHIVED AT DANS/EASY, BUT NOT ACCESSIBLE HERE. TO VIEW A LIST OF ...

Supplemental__Figure_1 – Supplemental material for Effectiveness and safety of secukinumab for psoriasis in real-world practice: analysis of subgroups stratified by prior biologic failure or reimbursement

Tzong-Yun Ger (6599690)
Yu-Huei Huang (6599693)
Rosaline Chung-yee Hui (6599696)
Tsen-Fang Tsai (799942)
Hsien-Yi Chiu (799936)

April 2019

Supplemental material, Supplemental__Figure_1 for Effectiveness and safety of secukinumab for psoria...

Supplemental Material - Factors Associated With Treatment Escalation for Psoriasis: An Analysis of Electronic Health Records Data

Jamie L. W. Rhoads (17603501)
William N. Malatestinic (9435331)
Russel Burge (3556160)
Michael L. Ganz (8429814)
Kristina C. Duffin (17603504)

December 2023

Supplemental Material for Factors Associated With Treatment Escalation for Psoriasis: An Analysis of...

Supplement_1_-_June_8_-_JCMS – Supplemental material for Satisfaction and Awareness of Systemic Psoriasis Treatments: A National Survey Comparing Biologic and Nonbiologic Users

Arvin Ighani (5196215)
Ashley M. Yu (6399680)
Vijay K. Sandhu (6399683)
Benjamin Barankin (6399686)
Morris F. Manolson (5518172)

February 2019

Supplemental material, Supplement_1_-_June_8_-_JCMS for Satisfaction and Awareness of Systemic Psori...

Supplemental material (Factors for Psoriatic Arthritis in Psoriasis patients)

Xie, W (via Mendeley Data)

August 2020

This is additional supporting information for an article entitled "Modifiable Lifestyle and Environm...

Supplemental Material - Predicting Psoriatic Arthritis in Psoriasis Patients – A Swiss Registry Study

Mia-Louise Nielsen (17428774)
Troels C. Petersen (14254517)
Lara Valeska Maul (9387466)
Jacob P. Thyssen (8833790)
Simon F. Thomsen (17428777)
Jashin J. Wu (5145644)
Alexander A. Navarini (5149958)
Thomas Kündig (17428780)
Nikhil Yawalkar (2987304)
Christoph Schlapbach (12110949)
Wolf-Henning Boehncke (229378)
Curdin Conrad (8725163)
Antonio Cozzio (5149964)
Raphael Micheroli (4260031)
Lars Erik Kristensen (68492)
Alexander Egeberg (6613775)
Julia-Tatjana Maul (9387464)

November 2023

Supplemental Material for Predicting Psoriatic Arthritis in Psoriasis Patients – A Swiss Registry St...

Table_1_Major cardiovascular events under biologic psoriasis therapies: a 19-year real-world analysis of FAERS data.docx

Lingqing Ding (17916311)
Congqin Chen (17916314)
Yongkuan Yang (17916317)
Xiaoting Zhang (439516)

February 2024

ObjectiveOver the years when biologic psoriasis therapies (TNF inhibitors, IL-12/23 inhibitors, IL-2...

Supplemental Material, Appendix_2_Panel,_Teams_Involved - 2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis

Jasvinder A. Singh (484385)
Gordon Guyatt (56595)
Alexis Ogdie (6060134)
Dafna D. Gladman (4522396)
Chad Deal (6060137)
Atul Deodhar (3606365)
Maureen Dubreuil (6060140)
Jonathan Dunham (6060143)
M. Elaine Husni (5005829)
Sarah Kenny (6060146)
Jennifer Kwan-Morley (6060149)
Janice Lin (1961875)
Paula Marchetta (6060152)
Philip J. Mease (4910524)
Joseph F. Merola (5365979)
Julie Miner (6060155)
Christopher T. Ritchlin (647915)
Bernadette Siaton (6060158)
Benjamin J. Smith (332956)
Abby S. Van Voorhees (6060161)
Anna Helena Jonsson (6060164)
Amit Aakash Shah (6060167)
Nancy Sullivan (6060170)
Marat Turgunbaev (6060173)
Laura C. Coates (5081063)
Alice Gottlieb (218992)
Marina Magrey (3945329)
W. Benjamin Nowell (6060176)
Ana-Maria Orbai (797190)
Soumya M. Reddy (6060179)
Jose U. Scher (6060182)
Evan Siegel (6060185)
Michael Siegel (1481731)
Jessica A. Walsh (5585778)
Amy S. Turner (6060188)
James Reston (6060191)

December 2018

Supplemental Material, Appendix_2_Panel,_Teams_Involved for 2018 American College of Rheumatology/Na...

Supplemental Material, Appendixs5_revised - 2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis

Jasvinder A. Singh (484385)
Gordon Guyatt (56595)
Alexis Ogdie (6060134)
Dafna D. Gladman (4522396)
Chad Deal (6060137)
Atul Deodhar (3606365)
Maureen Dubreuil (6060140)
Jonathan Dunham (6060143)
M. Elaine Husni (5005829)
Sarah Kenny (6060146)
Jennifer Kwan-Morley (6060149)
Janice Lin (1961875)
Paula Marchetta (6060152)
Philip J. Mease (4910524)
Joseph F. Merola (5365979)
Julie Miner (6060155)
Christopher T. Ritchlin (647915)
Bernadette Siaton (6060158)
Benjamin J. Smith (332956)
Abby S. Van Voorhees (6060161)
Anna Helena Jonsson (6060164)
Amit Aakash Shah (6060167)
Nancy Sullivan (6060170)
Marat Turgunbaev (6060173)
Laura C. Coates (5081063)
Alice Gottlieb (218992)
Marina Magrey (3945329)
W. Benjamin Nowell (6060176)
Ana-Maria Orbai (797190)
Soumya M. Reddy (6060179)
Jose U. Scher (6060182)
Evan Siegel (6060185)
Michael Siegel (1481731)
Jessica A. Walsh (5585778)
Amy S. Turner (6060188)
James Reston (6060191)

December 2018

Supplemental Material, Appendixs5_revised for 2018 American College of Rheumatology/National Psorias...

Supplemental Table 1 for: Real-world trends in biologic, oral systemic and phototherapy in United States patients with psoriasis or psoriatic arthritis

Singh, P

Supplemental Table 1 for "Real-world trends in biologic, oral systemic and phototherapy in United St...

Supplement_Table_S1 – Supplemental material for Effectiveness and safety of secukinumab for psoriasis in real-world practice: analysis of subgroups stratified by prior biologic failure or reimbursement

Tzong-Yun Ger (6599690)
Yu-Huei Huang (6599693)
Rosaline Chung-yee Hui (6599696)
Tsen-Fang Tsai (799942)
Hsien-Yi Chiu (799936)

April 2019

Supplemental material, Supplement_Table_S1 for Effectiveness and safety of secukinumab for psoriasis...

Supplement_Table_S2 – Supplemental material for Effectiveness and safety of secukinumab for psoriasis in real-world practice: analysis of subgroups stratified by prior biologic failure or reimbursement

Tzong-Yun Ger (6599690)
Yu-Huei Huang (6599693)
Rosaline Chung-yee Hui (6599696)
Tsen-Fang Tsai (799942)
Hsien-Yi Chiu (799936)

April 2019

Supplemental material, Supplement_Table_S2 for Effectiveness and safety of secukinumab for psoriasis...

Supplement_Table_S3 – Supplemental material for Effectiveness and safety of secukinumab for psoriasis in real-world practice: analysis of subgroups stratified by prior biologic failure or reimbursement

Tzong-Yun Ger (6599690)
Yu-Huei Huang (6599693)
Rosaline Chung-yee Hui (6599696)
Tsen-Fang Tsai (799942)
Hsien-Yi Chiu (799936)

April 2019

Supplemental material, Supplement_Table_S3 for Effectiveness and safety of secukinumab for psoriasis...

Supplement_Table_S4 – Supplemental material for Effectiveness and safety of secukinumab for psoriasis in real-world practice: analysis of subgroups stratified by prior biologic failure or reimbursement

Tzong-Yun Ger (6599690)
Yu-Huei Huang (6599693)
Rosaline Chung-yee Hui (6599696)
Tsen-Fang Tsai (799942)
Hsien-Yi Chiu (799936)

April 2019

Supplemental material, Supplement_Table_S4 for Effectiveness and safety of secukinumab for psoriasis...

Table S1 -Supplemental material for Quantitative evaluation to efficacy and safety of therapies for psoriasis: A network meta-analysis

Jingjing Lv (5276036)
Dongmei Zhou (786550)
Yan Wang (15435)
Jingxia Zhao (5276045)
Zhaoxia Chen (5276039)
Jinchao Zhang (1324296)
Tingting Di (5276042)
Jing Hu (41899)
Bo Li (112195)
Ping Li (31981)
Feng Huang (62988)

May 2018

<p>Supplemental material, Table S1 for Quantitative evaluation to efficacy and safety of therapies f...

Supplemental Table: Medicaid coverage per state for biologic medications and Apremilast in the systemic treatment of psoriasis

Falotico, J (via Mendeley Data)

November 2021

Supplemental TableTHIS DATASET IS ARCHIVED AT DANS/EASY, BUT NOT ACCESSIBLE HERE. TO VIEW A LIST OF ...

Supplemental__Figure_1 – Supplemental material for Effectiveness and safety of secukinumab for psoriasis in real-world practice: analysis of subgroups stratified by prior biologic failure or reimbursement

Tzong-Yun Ger (6599690)
Yu-Huei Huang (6599693)
Rosaline Chung-yee Hui (6599696)
Tsen-Fang Tsai (799942)
Hsien-Yi Chiu (799936)

April 2019

Supplemental material, Supplemental__Figure_1 for Effectiveness and safety of secukinumab for psoria...

Supplemental Material - Factors Associated With Treatment Escalation for Psoriasis: An Analysis of Electronic Health Records Data

Jamie L. W. Rhoads (17603501)
William N. Malatestinic (9435331)
Russel Burge (3556160)
Michael L. Ganz (8429814)
Kristina C. Duffin (17603504)

December 2023

Supplemental Material for Factors Associated With Treatment Escalation for Psoriasis: An Analysis of...

Supplement_1_-_June_8_-_JCMS – Supplemental material for Satisfaction and Awareness of Systemic Psoriasis Treatments: A National Survey Comparing Biologic and Nonbiologic Users

Arvin Ighani (5196215)
Ashley M. Yu (6399680)
Vijay K. Sandhu (6399683)
Benjamin Barankin (6399686)
Morris F. Manolson (5518172)

February 2019

Supplemental material, Supplement_1_-_June_8_-_JCMS for Satisfaction and Awareness of Systemic Psori...

Supplemental material (Factors for Psoriatic Arthritis in Psoriasis patients)

Xie, W (via Mendeley Data)

August 2020

This is additional supporting information for an article entitled "Modifiable Lifestyle and Environm...

Supplemental Material - Predicting Psoriatic Arthritis in Psoriasis Patients – A Swiss Registry Study

Mia-Louise Nielsen (17428774)
Troels C. Petersen (14254517)
Lara Valeska Maul (9387466)
Jacob P. Thyssen (8833790)
Simon F. Thomsen (17428777)
Jashin J. Wu (5145644)
Alexander A. Navarini (5149958)
Thomas Kündig (17428780)
Nikhil Yawalkar (2987304)
Christoph Schlapbach (12110949)
Wolf-Henning Boehncke (229378)
Curdin Conrad (8725163)
Antonio Cozzio (5149964)
Raphael Micheroli (4260031)
Lars Erik Kristensen (68492)
Alexander Egeberg (6613775)
Julia-Tatjana Maul (9387464)

November 2023

Supplemental Material for Predicting Psoriatic Arthritis in Psoriasis Patients – A Swiss Registry St...

Table_1_Major cardiovascular events under biologic psoriasis therapies: a 19-year real-world analysis of FAERS data.docx

Lingqing Ding (17916311)
Congqin Chen (17916314)
Yongkuan Yang (17916317)
Xiaoting Zhang (439516)

February 2024

ObjectiveOver the years when biologic psoriasis therapies (TNF inhibitors, IL-12/23 inhibitors, IL-2...

Supplemental Material, Appendix_2_Panel,_Teams_Involved - 2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis

Jasvinder A. Singh (484385)
Gordon Guyatt (56595)
Alexis Ogdie (6060134)
Dafna D. Gladman (4522396)
Chad Deal (6060137)
Atul Deodhar (3606365)
Maureen Dubreuil (6060140)
Jonathan Dunham (6060143)
M. Elaine Husni (5005829)
Sarah Kenny (6060146)
Jennifer Kwan-Morley (6060149)
Janice Lin (1961875)
Paula Marchetta (6060152)
Philip J. Mease (4910524)
Joseph F. Merola (5365979)
Julie Miner (6060155)
Christopher T. Ritchlin (647915)
Bernadette Siaton (6060158)
Benjamin J. Smith (332956)
Abby S. Van Voorhees (6060161)
Anna Helena Jonsson (6060164)
Amit Aakash Shah (6060167)
Nancy Sullivan (6060170)
Marat Turgunbaev (6060173)
Laura C. Coates (5081063)
Alice Gottlieb (218992)
Marina Magrey (3945329)
W. Benjamin Nowell (6060176)
Ana-Maria Orbai (797190)
Soumya M. Reddy (6060179)
Jose U. Scher (6060182)
Evan Siegel (6060185)
Michael Siegel (1481731)
Jessica A. Walsh (5585778)
Amy S. Turner (6060188)
James Reston (6060191)

December 2018

Supplemental Material, Appendix_2_Panel,_Teams_Involved for 2018 American College of Rheumatology/Na...

Supplemental Material, Appendixs5_revised - 2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis

Jasvinder A. Singh (484385)
Gordon Guyatt (56595)
Alexis Ogdie (6060134)
Dafna D. Gladman (4522396)
Chad Deal (6060137)
Atul Deodhar (3606365)
Maureen Dubreuil (6060140)
Jonathan Dunham (6060143)
M. Elaine Husni (5005829)
Sarah Kenny (6060146)
Jennifer Kwan-Morley (6060149)
Janice Lin (1961875)
Paula Marchetta (6060152)
Philip J. Mease (4910524)
Joseph F. Merola (5365979)
Julie Miner (6060155)
Christopher T. Ritchlin (647915)
Bernadette Siaton (6060158)
Benjamin J. Smith (332956)
Abby S. Van Voorhees (6060161)
Anna Helena Jonsson (6060164)
Amit Aakash Shah (6060167)
Nancy Sullivan (6060170)
Marat Turgunbaev (6060173)
Laura C. Coates (5081063)
Alice Gottlieb (218992)
Marina Magrey (3945329)
W. Benjamin Nowell (6060176)
Ana-Maria Orbai (797190)
Soumya M. Reddy (6060179)
Jose U. Scher (6060182)
Evan Siegel (6060185)
Michael Siegel (1481731)
Jessica A. Walsh (5585778)
Amy S. Turner (6060188)
James Reston (6060191)

December 2018

Supplemental Material, Appendixs5_revised for 2018 American College of Rheumatology/National Psorias...

Supplemental Table 1 for: Real-world trends in biologic, oral systemic and phototherapy in United States patients with psoriasis or psoriatic arthritis

Abstract

Extracted data

Supplemental Table 1 for: Real-world trends in biologic, oral systemic and phototherapy in United States patients with psoriasis or psoriatic arthritis

Abstract

Extracted data

Related items

Related items